As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

Dec 10 (Reuters) - CervoMed (CRVO.O), opens new tab said on Tuesday its experimental drug for a common degenerative ... significantly reducing symptoms of dementia versus a placebo, but the ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

The drug was developed from methylene blue, a medicine previously used to treat malaria. Professor Alistair Burns, former NHS clinical director for dementia ... "After no new therapies for ...

Nov. 19, 2024 — Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new ... Earlier Diabetes Diagnosis Linked to Dementia Risk Nov. 19, 2024 ...

The new Center for Genetics Guided Dementia Discovery ... and will engage in immuno-dementia drug discovery research focusing on neural inflammation and the immune system based on strong human ...

Commenting on the new study, Alzheimer’s Research ... have a protective effect for the diseases that cause dementia.” “As these drugs have already been shown to be safe for use in people ...

This is “equally important” as any new drug, Prof Hardy stresses ... the NHS the opportunity to kick a necessary improvement in dementia care down the road.” He is deeply concerned by ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...